Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
302
-
Total 13F shares, excl. options
-
82.7M
-
Shares change
-
+6.39M
-
Total reported value, excl. options
-
$6.71B
-
Value change
-
+$523M
-
Put/Call ratio
-
2.46
-
Number of buys
-
203
-
Number of sells
-
-85
-
Price
-
$81.13
Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q2 2020
352 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q2 2020.
Guardant Health, Inc. - Common Stock (GH) has 302 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 82.7M shares
of 124M outstanding shares and own 66.8% of the company stock.
Largest 10 shareholders include SB INVESTMENT ADVISERS (UK) LTD (14M shares), VANGUARD GROUP INC (6.32M shares), MORGAN STANLEY (5.97M shares), BlackRock Inc. (4.57M shares), Clearbridge Investments, LLC (3.35M shares), JENNISON ASSOCIATES LLC (3.34M shares), VIKING GLOBAL INVESTORS LP (3.07M shares), Nuveen Asset Management, LLC (3M shares), FRED ALGER MANAGEMENT, LLC (2.09M shares), and Capital Research Global Investors (1.95M shares).
This table shows the top 302 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.